配位化学表明,独立观察到的二甲双胍和 Zn2+ 对 COVID-19 的益处并不是独立的

IF 4.1 3区 生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY
Thomas D. Lockwood
{"title":"配位化学表明,独立观察到的二甲双胍和 Zn2+ 对 COVID-19 的益处并不是独立的","authors":"Thomas D. Lockwood","doi":"10.1007/s10534-024-00590-5","DOIUrl":null,"url":null,"abstract":"<div><p>Independent trials indicate that either oral Zn<sup>2+</sup> or metformin can separately improve COVID-19 outcomes by approximately 40%. Coordination chemistry predicts a mechanistic relationship and therapeutic synergy. Zn<sup>2+</sup> deficit is a known risk factor for both COVID-19 and non-infectious inflammation. Most dietary Zn<sup>2+</sup> is not absorbed. Metformin is a naked ligand that presumably increases intestinal Zn<sup>2+</sup> bioavailability and active absorption by cation transporters known to transport metformin. Intracellular Zn<sup>2+</sup> provides a natural buffer of many protease reactions; the variable “set point” is determined by Zn<sup>2+</sup> regulation or availability. A Zn<sup>2+</sup>-interactive protease network is suggested here. The two viral cysteine proteases are therapeutic targets against COVID-19. Viral and many host proteases are submaximally inhibited by exchangeable cell Zn<sup>2+</sup>. Inhibition of cysteine proteases can improve COVID-19 outcomes and non-infectious inflammation. Metformin reportedly enhances the natural moderating effect of Zn<sup>2+</sup> on bioassayed proteome degradation. Firstly, the dissociable metformin–Zn<sup>2+</sup> complex could be actively transported by intestinal cation transporters; thereby creating artificial pathways of absorption and increased body Zn<sup>2+</sup> content. Secondly, metformin Zn<sup>2+</sup> coordination can create a non-natural protease inhibitor independent of cell Zn<sup>2+</sup> content. Moderation of peptidolytic reactions by either or both mechanisms could slow (a) viral multiplication (b) viral invasion and (c) the pathogenic host inflammatory response. These combined actions could allow development of acquired immunity to clear the infection before life-threatening inflammation. Nirmatrelvir (Paxlovid®) opposes COVID-19 by selective inhibition the viral main protease by a Zn<sup>2+</sup>-independent mechanism. Pending safety evaluation, predictable synergistic benefits of metformin and Zn<sup>2+</sup>, and perhaps metformin/Zn<sup>2+</sup>/Paxlovid® co-administration should be investigated.</p></div>","PeriodicalId":491,"journal":{"name":"Biometals","volume":"37 4","pages":"983 - 1022"},"PeriodicalIF":4.1000,"publicationDate":"2024-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s10534-024-00590-5.pdf","citationCount":"0","resultStr":"{\"title\":\"Coordination chemistry suggests that independently observed benefits of metformin and Zn2+ against COVID-19 are not independent\",\"authors\":\"Thomas D. Lockwood\",\"doi\":\"10.1007/s10534-024-00590-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Independent trials indicate that either oral Zn<sup>2+</sup> or metformin can separately improve COVID-19 outcomes by approximately 40%. Coordination chemistry predicts a mechanistic relationship and therapeutic synergy. Zn<sup>2+</sup> deficit is a known risk factor for both COVID-19 and non-infectious inflammation. Most dietary Zn<sup>2+</sup> is not absorbed. Metformin is a naked ligand that presumably increases intestinal Zn<sup>2+</sup> bioavailability and active absorption by cation transporters known to transport metformin. Intracellular Zn<sup>2+</sup> provides a natural buffer of many protease reactions; the variable “set point” is determined by Zn<sup>2+</sup> regulation or availability. A Zn<sup>2+</sup>-interactive protease network is suggested here. The two viral cysteine proteases are therapeutic targets against COVID-19. Viral and many host proteases are submaximally inhibited by exchangeable cell Zn<sup>2+</sup>. Inhibition of cysteine proteases can improve COVID-19 outcomes and non-infectious inflammation. Metformin reportedly enhances the natural moderating effect of Zn<sup>2+</sup> on bioassayed proteome degradation. Firstly, the dissociable metformin–Zn<sup>2+</sup> complex could be actively transported by intestinal cation transporters; thereby creating artificial pathways of absorption and increased body Zn<sup>2+</sup> content. Secondly, metformin Zn<sup>2+</sup> coordination can create a non-natural protease inhibitor independent of cell Zn<sup>2+</sup> content. Moderation of peptidolytic reactions by either or both mechanisms could slow (a) viral multiplication (b) viral invasion and (c) the pathogenic host inflammatory response. These combined actions could allow development of acquired immunity to clear the infection before life-threatening inflammation. Nirmatrelvir (Paxlovid®) opposes COVID-19 by selective inhibition the viral main protease by a Zn<sup>2+</sup>-independent mechanism. Pending safety evaluation, predictable synergistic benefits of metformin and Zn<sup>2+</sup>, and perhaps metformin/Zn<sup>2+</sup>/Paxlovid® co-administration should be investigated.</p></div>\",\"PeriodicalId\":491,\"journal\":{\"name\":\"Biometals\",\"volume\":\"37 4\",\"pages\":\"983 - 1022\"},\"PeriodicalIF\":4.1000,\"publicationDate\":\"2024-04-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://link.springer.com/content/pdf/10.1007/s10534-024-00590-5.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biometals\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://link.springer.com/article/10.1007/s10534-024-00590-5\",\"RegionNum\":3,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biometals","FirstCategoryId":"99","ListUrlMain":"https://link.springer.com/article/10.1007/s10534-024-00590-5","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

独立试验表明,口服 Zn2+ 或二甲双胍可分别将 COVID-19 的疗效提高约 40%。配位化学预测了两者之间的机理关系和治疗协同作用。Zn2+ 缺乏是 COVID-19 和非感染性炎症的已知风险因素。大多数膳食 Zn2+ 不会被吸收。二甲双胍是一种裸配体,可增加肠道 Zn2+ 的生物利用度,并通过已知可转运二甲双胍的阳离子转运体主动吸收。细胞内 Zn2+ 是许多蛋白酶反应的天然缓冲剂;可变的 "设定点 "由 Zn2+ 的调节或可用性决定。这里提出了一个 Zn2+ 相互作用的蛋白酶网络。两种病毒半胱氨酸蛋白酶是针对 COVID-19 的治疗靶点。病毒和许多宿主蛋白酶受到可交换细胞 Zn2+ 的亚极限抑制。抑制半胱氨酸蛋白酶可以改善 COVID-19 的疗效和非感染性炎症。据报道,二甲双胍增强了 Zn2+ 对生物测定蛋白质组降解的天然调节作用。首先,可解离的二甲双胍-Zn2+复合物可被肠道阳离子转运体主动转运,从而形成人工吸收途径并增加体内 Zn2+含量。其次,二甲双胍 Zn2+ 配位可产生一种非天然蛋白酶抑制剂,与细胞 Zn2+ 含量无关。通过这两种机制中的一种或两种来调节肽解反应,可以减缓(a)病毒繁殖(b)病毒入侵和(c)致病性宿主炎症反应。这些综合作用可使获得性免疫得以发展,从而在出现危及生命的炎症之前清除感染。Nirmatrelvir (Paxlovid®) 通过 Zn2+ 非依赖性机制选择性抑制病毒主蛋白酶,从而对抗 COVID-19。在进行安全性评估之前,应研究二甲双胍和 Zn2+ 的可预见协同作用,以及二甲双胍/Zn2+/Paxlovid® 联合用药的可能性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Coordination chemistry suggests that independently observed benefits of metformin and Zn2+ against COVID-19 are not independent

Coordination chemistry suggests that independently observed benefits of metformin and Zn2+ against COVID-19 are not independent

Independent trials indicate that either oral Zn2+ or metformin can separately improve COVID-19 outcomes by approximately 40%. Coordination chemistry predicts a mechanistic relationship and therapeutic synergy. Zn2+ deficit is a known risk factor for both COVID-19 and non-infectious inflammation. Most dietary Zn2+ is not absorbed. Metformin is a naked ligand that presumably increases intestinal Zn2+ bioavailability and active absorption by cation transporters known to transport metformin. Intracellular Zn2+ provides a natural buffer of many protease reactions; the variable “set point” is determined by Zn2+ regulation or availability. A Zn2+-interactive protease network is suggested here. The two viral cysteine proteases are therapeutic targets against COVID-19. Viral and many host proteases are submaximally inhibited by exchangeable cell Zn2+. Inhibition of cysteine proteases can improve COVID-19 outcomes and non-infectious inflammation. Metformin reportedly enhances the natural moderating effect of Zn2+ on bioassayed proteome degradation. Firstly, the dissociable metformin–Zn2+ complex could be actively transported by intestinal cation transporters; thereby creating artificial pathways of absorption and increased body Zn2+ content. Secondly, metformin Zn2+ coordination can create a non-natural protease inhibitor independent of cell Zn2+ content. Moderation of peptidolytic reactions by either or both mechanisms could slow (a) viral multiplication (b) viral invasion and (c) the pathogenic host inflammatory response. These combined actions could allow development of acquired immunity to clear the infection before life-threatening inflammation. Nirmatrelvir (Paxlovid®) opposes COVID-19 by selective inhibition the viral main protease by a Zn2+-independent mechanism. Pending safety evaluation, predictable synergistic benefits of metformin and Zn2+, and perhaps metformin/Zn2+/Paxlovid® co-administration should be investigated.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Biometals
Biometals 生物-生化与分子生物学
CiteScore
5.90
自引率
8.60%
发文量
111
审稿时长
3 months
期刊介绍: BioMetals is the only established journal to feature the important role of metal ions in chemistry, biology, biochemistry, environmental science, and medicine. BioMetals is an international, multidisciplinary journal singularly devoted to the rapid publication of the fundamental advances of both basic and applied research in this field. BioMetals offers a forum for innovative research and clinical results on the structure and function of: - metal ions - metal chelates, - siderophores, - metal-containing proteins - biominerals in all biosystems. - BioMetals rapidly publishes original articles and reviews. BioMetals is a journal for metals researchers who practice in medicine, biochemistry, pharmacology, toxicology, microbiology, cell biology, chemistry, and plant physiology who are based academic, industrial and government laboratories.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信